CMMB
insider transactionsChemomab Therapeutics Ltd. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+9.8K
9.8K buy · 0 sell
Net value · 90d
$20.2K
$20.2K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
2
9.8K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·J
George Adi Mor KEY
Chief Executive Officer
—
18.8K sh
-
Other·J
George Adi Mor KEY
Chief Executive Officer
—
31.7K sh
-
Buy·P
George Adi Mor KEY
Chief Executive Officer
$10.2K
4.9K sh · $2.08
Own +4%
-
Buy·P
George Adi Mor KEY
Chief Executive Officer
$10.0K
4.9K sh · $2.05
Own +4%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | George Adi Mor KEY | Other J | 18.8K | — |
| May 29, 2026 | George Adi Mor KEY | Other J | 31.7K | — |
| May 29, 2026 | George Adi Mor KEY | Buy P | 4.9K | $10.2K |
| May 29, 2026 | George Adi Mor KEY | Buy P | 4.9K | $10.0K |
About CMMB insider trading
This page tracks insider transactions for Chemomab Therapeutics Ltd. (CMMB) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.